Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Gaming and Leisure Properties
GLPI
$11.1B
| $151M | 0.13% |
4,351,932
-1,790,970
| -29% | -$55.8M |
2014 Q1
25 quarters
|
|
152
ServiceNow
NOW
$143B
| $150M | 0.13% |
1,856,500
+947,500
| +104% | +$66.9M |
2020 Q1
1 quarter
|
|
153
Corcept Therapeutics
CORT
$12.8B
| $150M | 0.13% |
8,919,996
+617,155
| +7% | +$8.67M |
2015 Q1
21 quarters
|
|
|
TERP
154
DELISTED
TerraForm Power, Inc
TERP
| $150M | 0.13% |
8,112,816
-711,100
| -8% | -$12.6M |
2017 Q4
10 quarters
|
|
155
Pacira BioSciences
PCRX
$1.45B
| $150M | 0.13% |
2,850,797
+382,655
| +16% | +$16M |
2018 Q3
7 quarters
|
|
156
TSMC
TSM
$2.36T
| $148M | 0.13% |
2,601,999
-2,828,198
| -52% | -$149M |
2018 Q1
9 quarters
|
|
157
Procter & Gamble
PG
$348B
| $148M | 0.13% |
1,234,529
-1,147,532
| -48% | -$134M |
2020 Q1
1 quarter
|
|
158
J.M. Smucker
SJM
$12.7B
| $147M | 0.13% |
1,386,580
+915,799
| +195% | +$103M |
2019 Q2
4 quarters
|
|
159
Alphabet (Google) Class A
GOOGL
$4.26T
| $146M | 0.13% |
2,062,960
-424,000
| -17% | -$28.6M |
2018 Q3
7 quarters
|
|
160
Toyota
TM
$219B
| $146M | 0.13% |
1,163,710
+400
| +0% | +$49.6K |
2013 Q3
27 quarters
|
|
161
Equinor
EQNR
$102B
| $145M | 0.13% |
10,021,861
-2,635,200
| -21% | -$37M |
2015 Q1
21 quarters
|
|
162
AES
AES
$10.7B
| $145M | 0.12% |
9,977,800
-3,900,379
| -28% | -$51.2M |
2018 Q3
7 quarters
|
|
163
Shopify
SHOP
$214B
| $144M | 0.12% |
1,519,000
+762,000
| +101% | +$52.9M |
2020 Q1
1 quarter
|
|
164
Chemed
CHE
$6.5B
| $144M | 0.12% |
319,000
+41,071
| +15% | +$18.3M |
2014 Q1
25 quarters
|
|
165
Okta
OKTA
$38.7B
| $143M | 0.12% |
714,300
+504,700
| +241% | +$85.7M |
2020 Q1
1 quarter
|
|
166
Campbell Soup
CPB
$5.74B
| $143M | 0.12% |
2,878,709
+1,016,332
| +55% | +$50.5M |
2020 Q1
1 quarter
|
|
167
SSR Mining
SSRM
$6.87B
| $141M | 0.12% |
6,609,228
-380,400
| -5% | -$6.82M |
2017 Q3
11 quarters
|
|
168
NetApp
NTAP
$45.6B
| $140M | 0.12% |
3,163,172
-121,668
| -4% | -$5.23M |
2013 Q4
26 quarters
|
|
169
Alkermes
ALKS
$6.65B
| $138M | 0.12% |
7,135,013
-46,100
| -0.6% | -$748K |
2018 Q4
6 quarters
|
|
170
RenaissanceRe
RNR
$13.8B
| $138M | 0.12% |
807,097
-12,400
| -2% | -$2.04M |
2014 Q4
22 quarters
|
|
171
RB Global
RBA
$15.2B
| $135M | 0.12% |
3,318,908
+957,105
| +41% | +$39.1M |
2018 Q4
6 quarters
|
|
172
Wingstop
WING
$3.22B
| $135M | 0.12% |
971,915
-144,500
| -13% | -$16.8M |
2018 Q1
9 quarters
|
|
173
Telus
TU
$12.6B
| $134M | 0.12% |
8,011,780
-561,020
| -7% | -$9.34M |
2013 Q2
28 quarters
|
|
|
PINC
174
DELISTED
Premier
PINC
| $134M | 0.12% |
3,916,506
+359,100
| +10% | +$11.8M |
2018 Q2
8 quarters
|
|
175
Lyft
LYFT
$6B
| $134M | 0.12% |
4,051,969
+3,514,271
| +654% | +$111M |
2020 Q1
1 quarter
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.